No abstract available
Keywords:
Hodgkin lymphoma; anaplastic large-cell lymphoma; brentuximab vedotin; monoclonal antibody; primary refractory.
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Brentuximab Vedotin
-
Hodgkin Disease / drug therapy*
-
Humans
-
Immunoconjugates / therapeutic use*
-
Lymphoma, Large-Cell, Anaplastic / drug therapy*
-
Middle Aged
-
Recurrence
-
Retrospective Studies
-
Treatment Outcome
-
Young Adult
Substances
-
Antineoplastic Agents
-
Immunoconjugates
-
Brentuximab Vedotin